Clinical Trials | December 27, 2025
InnoCare Pharma gets green light for Phase II trial of oral lupus drug
CLE, a common form of lupus erythematosus, primarily causes diverse skin lesions
CLE, a common form of lupus erythematosus, primarily causes diverse skin lesions
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The study found that nerandomilast effectively slowed lung function decline in patients, with discontinuation rates similar to placebo
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
The expansion includes a larger technical and service team and increased local procurement
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
The company shall process the change of name application with BSE Ltd. in due course
The Signals Xynthetica solution brings AI-driven in-silico generation, predictive modeling, and experimental validation into a single, governed environment
The company operates a chain of mid-sized multi-speciality hospitals
Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation
Subscribe To Our Newsletter & Stay Updated
